Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Beth Beasley

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
The American Journal of Surgical Pathology|September 10, 2002
Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimensSiobhan A Nicholson, Mary Beth Beasley, Elizabeth Brambilla, et al.
Archives of Pathology & Laboratory Medicine|May 25, 2023
Pulmonary Pathology Society Survey on Practice Approaches in the Histologic Diagnosis of Fibrotic Interstitial Lung Disease: Consensus and OpportunitiesMaxwell L Smith, Mari Mino-Kenudson, Richard J Butterfield, et al.
Archives of Pathology & Laboratory Medicine|May 3, 2014
Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopyHangjun Wang, Camelia S Sima, Mary Beth Beasley, et al.
Journal of the American Society of Cytopathology|May 3, 2019
Fine-needle aspiration of small pulmonary nodules yields material for reliable molecular analysis of adenocarcinomasDianne Grunes, David Yankelevitz, Mary Beth Beasley, et al.
Archives of Pathology & Laboratory Medicine|January 6, 2011
Revolution in lung cancer: new challenges for the surgical pathologistPhilip T Cagle, Timothy C Allen, Sanja Dacic, et al.
NPJ Precision Oncology|November 20, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancerMing-Sound Tsao, Lynette Sholl, Michelle Shiller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2026
Update on pleural epithelioid mesothelioma: New insights for diagnosis and patient managementFrancoise Galateau Sallé, Mary Beth Beasley, Luka Brcic, et al.
Nature Reviews. Clinical Oncology|February 13, 2021
PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Cancer Research|September 26, 2019
Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell CarcinomaTakashi Sato, Seungyeul Yoo, Ranran Kong, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
The American Journal of Surgical Pathology|September 10, 2002
Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimensSiobhan A Nicholson, Mary Beth Beasley, Elizabeth Brambilla, et al.
Archives of Pathology & Laboratory Medicine|May 25, 2023
Pulmonary Pathology Society Survey on Practice Approaches in the Histologic Diagnosis of Fibrotic Interstitial Lung Disease: Consensus and OpportunitiesMaxwell L Smith, Mari Mino-Kenudson, Richard J Butterfield, et al.
Archives of Pathology & Laboratory Medicine|May 3, 2014
Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopyHangjun Wang, Camelia S Sima, Mary Beth Beasley, et al.
Journal of the American Society of Cytopathology|May 3, 2019
Fine-needle aspiration of small pulmonary nodules yields material for reliable molecular analysis of adenocarcinomasDianne Grunes, David Yankelevitz, Mary Beth Beasley, et al.
Archives of Pathology & Laboratory Medicine|January 6, 2011
Revolution in lung cancer: new challenges for the surgical pathologistPhilip T Cagle, Timothy C Allen, Sanja Dacic, et al.
NPJ Precision Oncology|November 20, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancerMing-Sound Tsao, Lynette Sholl, Michelle Shiller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2026
Update on pleural epithelioid mesothelioma: New insights for diagnosis and patient managementFrancoise Galateau Sallé, Mary Beth Beasley, Luka Brcic, et al.
Nature Reviews. Clinical Oncology|February 13, 2021
PD-L1 as a biomarker of response to immune-checkpoint inhibitorsDeborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapyVicki Leigh Keedy, Sarah Temin, Mark R Somerfield, et al.
Cancer Research|September 26, 2019
Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell CarcinomaTakashi Sato, Seungyeul Yoo, Ranran Kong, et al.
Pageof 12